Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant radiochemotherapy with tegafur and mitomycin in locally advanced anal canal cancer (dose-escalation)
2008-003767-39Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur and mitomycin c in squamous cell carcinoma of the anus, sponsored by Policlinico Gemelli. Primary endpoint: Maximum tolerated dose of tegafur. Started May 2009; status: completed.
02
Drugs
tegafurmitomycin c
03
Conditions
squamous cell carcinoma of the anus
Beyond the preview
Go deeper on 2008-003767-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003767-39.